Monthly Archives: June 2025

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.

LPC Chairs and Community Pharmacy England have met with MPs to discuss the value that pharmacies bring to local communities, as well as ways to address the continued pressures facing the sector. The Forum of LPC Chairs held in Parliament this week focussed on efforts to build an ever-stronger local voice for community pharmacy, including [...]

The post Strengthening our voice: LPC Chairs and MPs meet to discuss future of pharmacy appeared first on Community Pharmacy England.

As announced last month, Pharmacy First consultations carried out in March, April and May 2025 must be claimed by 11.59pm on 30th June 2025 to receive payment. Pharmacy owners are encouraged to check that all claims for this time period have been submitted to the NHS Business Services Authority on the MYS portal for payment. [...]

The post Pharmacy First: Have you claimed for your March-May consultations? appeared first on Community Pharmacy England.

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across the East of England and East and North Midlands are invited to ‘Future [...]

The post Eastern and East and North Midlands Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches MSN/2025/038 Tier 2 – medium impact Date of issue: 19/06/2025 Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August [...]

The post Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches appeared first on Community Pharmacy England.